Hermansky-Pudlak SyndromeSymptoms, Doctors, Treatments, Advances & More
Hermansky-Pudlak Syndrome Overview
Learn About Hermansky-Pudlak Syndrome
Hermansky-Pudlak syndrome is a disorder characterized by a condition called oculocutaneous albinism, which causes abnormally light coloring (pigmentation) of the skin, hair, and eyes. Affected individuals typically have fair skin and white or light-colored hair. People with this disorder have a higher than average risk of skin damage and skin cancers caused by long-term sun exposure. Oculocutaneous albinism reduces pigmentation of the colored part of the eye (iris) and the light-sensitive tissue at the back of the eye (retina). Reduced vision, rapid and involuntary eye movements (nystagmus), and increased sensitivity to light (photophobia) are also common in oculocutaneous albinism. In Hermansky-Pudlak syndrome, these vision problems usually remain stable after early childhood.
At least nine genes are associated with Hermansky-Pudlak syndrome. These genes provide instructions for making proteins that are used to make four distinct protein complexes. These protein complexes play a role in the formation and movement (trafficking) of a group of cell structures called lysosome-related organelles (LROs). LROs are very similar to compartments within the cell called lysosomes, which digest and recycle materials. However, LROs perform specialized functions and are found only in certain cell types. LROs have been identified in pigment-producing cells (melanocytes), blood-clotting cells (platelets), and lung cells.
Hermansky-Pudlak syndrome is a rare disorder in most populations and is estimated to affect 1 in 500,000 to 1,000,000 individuals worldwide. Type 1 is more common in Puerto Rico, particularly in the northwestern part of the island where about 1 in 1,800 people are affected. Type 3 is common in people from central Puerto Rico. Groups of affected individuals have been identified in many other regions, including India, Japan, the United Kingdom, and Western Europe.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Benoit Arveiler practices practicing medicine in Bordeaux, France. Mr. Arveiler is rated as an Elite expert by MediFind in the treatment of Hermansky-Pudlak Syndrome. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Albinism, Oculocutaneous Albinism, Oculocutaneous Albinism Type 1, and Hermansky-Pudlak Syndrome.
Eulalie Lasseaux practices practicing medicine in Bordeaux, France. Ms. Lasseaux is rated as an Elite expert by MediFind in the treatment of Hermansky-Pudlak Syndrome. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Albinism, Oculocutaneous Albinism Type 2, Oculocutaneous Albinism Type 1, and Hermansky-Pudlak Syndrome.
Tamio Suzuki practices practicing medicine in Yamagata, Japan. Mr. Suzuki is rated as an Elite expert by MediFind in the treatment of Hermansky-Pudlak Syndrome. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Hypomelanotic Disorder, Hermansky-Pudlak Syndrome, Oculocutaneous Albinism, Oculocutaneous Albinism Type 2, and Splenectomy.
Summary: Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism), bleeding problems due to a platelet abnormality (platelet storage pool defect), and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin). The disease can cause poor functioning of the lungs, intestine, kidneys, or heart. The major complicat...
Summary: Oculocutaneous albinism (OCA) is the most common type of albinism. People with OCA have little or no pigment (melanin) in their eyes, skin, and hair. This often leads to symptoms such as sensitivity to light, crossed or misaligned eyes, reduced vision, and involuntary eye movements. OCA type 1 is caused by changes in the tyrosinase gene, which results in a lack or reduced function of the tyrosinas...
Published Date: May 01, 2014
Published By: National Institutes of Health